Iradimed (IRMD) Market Capitalization (2014 - 2026)

Iradimed (IRMD) has reported Market Capitalization for 13 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 60.66% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 60.66% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 77.87% from the prior year.
• Market Capitalization was $1.2 billion for Q2 2026 at Iradimed, down from $1.2 billion in the prior quarter.
• Over five years, Market Capitalization peaked at $1.2 billion in Q4 2025 and troughed at $356.2 million in Q4 2022.
• A 5-year average of $692.2 million and a median of $601.3 million in 2023 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization tumbled 38.55% in 2022 and jumped 84.4% in 2026, its largest moves.
• Over 5 years, Market Capitalization stood at $356.2 million in 2022, then jumped by 68.72% to $601.0 million in 2023, then increased by 16.32% to $699.0 million in 2024, then jumped by 77.87% to $1.2 billion in 2025, then decreased by 1.73% to $1.2 billion in 2026.
• The last three Market Capitalization figures came in at $1.2 billion (Q2 2026), $1.2 billion (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.